Form 4: Chemours Director Courtney Mather Acquires Deferred Stock Units

Chemours Company Director Courtney Mather has acquired 2,292 deferred stock units, equivalent to common stock, valued at $11.45 per unit.

Summary

• Director Courtney Mather acquired 2,292 Deferred Stock Units (DSUs) in The Chemours Company.
• Each DSU is economically equivalent to one share of Chemours common stock.
• The DSUs were acquired at a price of $11.45 per unit on June 30, 2025.
• These units become payable to the reporting person upon the first month following their termination of service as a director.

Sentiment

Score: 6

Explanation: Slightly positive due to an insider acquiring equity, which generally signals confidence, but it's a routine compensation event rather than a discretionary open market purchase.

Positives

• The acquisition of deferred stock units by a director aligns their interests with shareholders, indicating confidence in the company's future performance.

Future Outlook

NA

Industry Context

This is a routine insider transaction filing specific to an individual director's equity compensation and does not provide broader industry context.

Stakeholder Impact

• Shareholders: The acquisition of equity by a director can be viewed positively as it aligns the director's interests with those of the shareholders.

Next Steps

• The deferred stock units will become payable upon the first month following Courtney Mather's termination of service as a director.

Key Dates

Recommendation

Keywords

Chemours Company, CC, Courtney Mather, Director, Deferred Stock Units, DSU, Insider Transaction, SEC Form 4, Equity Compensation, Executive Compensation